LB Pharmaceuticals Inc
LBRX
$18.76
$0.271.46%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/29/2025
-
MarketBeat
11/24/2025
-
GuruFocus
11/24/2025
-
Globe Newswire
11/14/2025
-
FiercePharma
11/12/2025
-
GuruFocus
11/12/2025
-
Globe Newswire
11/12/2025
-
GuruFocus
11/12/2025
-
TipRanks Financial Blog
11/12/2025
-
The Fly
11/12/2025
-
Globe Newswire
11/11/2025
-
TipRanks Financial Blog
11/10/2025
-
Ticker Report
11/9/2025
-
MarketBeat
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/6/2025
-
The Fly
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/3/2025
-
MarketBeat
10/14/2025
-
GuruFocus
10/14/2025
-
The Fly
10/14/2025
-
Globe Newswire
10/14/2025
-
MarketBeat
10/10/2025
-
MarketBeat
10/10/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Aug 17 and 21 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 605 0300
Address
One Pennsylvania Plaza
New York, NY 10119
New York, NY 10119
Country
Year Founded
Business Description
Sector
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead...
more